Table 1 Summary of patient’s characteristics.
Characteristic | SMM (n = 82) | MM (n = 223) |
|---|---|---|
Median age at diagnosis (range) | 63 years (37–85) | 59 years (30–75) |
Median age at sample collection (range) | 65 years (38–85) | 59 years (30–75) |
Median follow-up (95% CI) | 5.18 years (95% CI 3.53–6.89) | 8.14 years (95% CI 7.35–8.96). |
5-year progression-free survival (95% CI) to symptomatic MM | 69.9% (95% CI 58–83%) | NA |
5-year overall survival (95% CI) | 96.5% (95% CI 92–100%) | 6.17 years (95% CI 5.18–7.75) |
Timepoint | Diagnosis: 44% Follow-up: 56% after a median time 2.9 years from diagnosis | Diagnosis: 100% |
Gender ratio (female:male) | 1:1.15 | 1:1.8 |
Race | 24% African-American 71% White-Caucasian 5% Other (Native American, Pacific Islander or unknown) | 10% African-American 88% White-Caucasian 2% Other (Native American, Pacific Islander or unknown) |
Isotype | IgA: 30% (n = 25) IgG: 60% (n = 49) IGD: 1.2% (n = 1) LCO: 8% (n = 7) |
